These novel whole transcriptome RNA sequencing reference materials from SeraCare enable the development and validation of next generation sequencing (NGS) assays for the screening of 22 fusion genes with clinical applications in oncology. Offered as a purified RNA mix ready for RNA-seq NGS library preparation, the Seraseq® reference materials enable the development of assays for the detection of known and novel fusion targets commonly assayed in pan-cancer disease profiling.
Benefits of using the Seraseq whole transcriptome RNA reference standards
- 22 pan-cancer RNA gene fusions provided in each sample
- Ideal for pan-cancer disease profiling
- Ready for total RNA transcriptome seq library prep
- Accurately quantitated by digital PCR - >20,000 copies/µl per fusion target
- Fusion constructs are blended into total RNA from well-characterised GM24385 cell line as wild-type background
- Manufactured in GMP-compliant and ISO 13485-certified facilities
Product specifications
| Number of fusions | 22 |
|---|---|
| Concentration | 50 ng/µl |
| Fill volume | 20 µl |
| Total mass | 1 µg |
| Format | Purified RNA |
| Buffer | 1mM Tris; pH 8 |
Material available for download
Seraseq whole transcriptome RNA seq mix flyer
Seraseq whole transcriptome RNA seq mix datasheet
Products
No products are currently available in this category.
